ATIN — Athanase Innovation AB Share Price
- SEK353.15m
- SEK52.96m
- SEK115.27m
- 45
- 28
- 13
- 15
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.82 | ||
Price to Tang. Book | 0.84 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 4.53 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -10.6% | ||
Return on Equity | -8.94% | ||
Operating Margin | -58.82% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | SEKm | 42.43 | 7.06 | 6.38 | 19.27 | 115.27 | n/a | n/a | 22.35% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -1.82 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Athanase Innovation AB is a Sweden-based company primarily engaged in the financial services industry. The Company focuses on investing in early-stage companies with technologies in sectors such as life sciences, software, and clean technology. Athanase Innovation AB key product is the investment portfolio, which is a collection of equity investments in companies. It aims to create long-term value for investors by supporting the growth and development of technology and innovation companies. Athanase Innovation AB utilizes various technologies, including Artificial Intelligence (AI), to enhance their investment strategies. The Company is committed to fostering innovation and driving progress in emerging industries.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- January 23rd, 2017
- Public Since
- May 8th, 2017
- No. of Employees
- 31
- Sector
- Investment Banking & Investment Services
- Industry
- Financials
- Exchange
OMX Nordic Exchange Stockholm
- Shares in Issue
- 19,297,641

- Address
- Birger Jarlsgatan 6, STOCKHOLM, 114 34
- Web
- https://athanaseinnovation.com/
- Phone
- +46 31171300
- Auditors
- Ernst & Young AB
Upcoming Events for ATIN
Similar to ATIN
ABG Sundal Collier Holding ASA
OMX Nordic Exchange Stockholm
Adventure Box Technology AB (publ)
OMX Nordic Exchange Stockholm
Alpcot Holding AB (publ)
OMX Nordic Exchange Stockholm
Aquila Holdings ASA
OMX Nordic Exchange Stockholm
Avanza Bank Holding AB
OMX Nordic Exchange Stockholm
FAQ
As of Today at 19:24 UTC, shares in Athanase Innovation AB are trading at SEK20.20. This share price information is delayed by 15 minutes.
Shares in Athanase Innovation AB last closed at SEK20.20 and the price had moved by +18.82% over the past 365 days. In terms of relative price strength the Athanase Innovation AB share price has outperformed the FTSE Global All Cap Index by +12.94% over the past year.
There is no consensus recommendation for this security.
Find out moreAthanase Innovation AB does not currently pay a dividend.
Athanase Innovation AB does not currently pay a dividend.
Athanase Innovation AB does not currently pay a dividend.
To buy shares in Athanase Innovation AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK20.20, shares in Athanase Innovation AB had a market capitalisation of SEK389.81m.
Here are the trading details for Athanase Innovation AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: ATIN
Based on an overall assessment of its quality, value and momentum Athanase Innovation AB is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Athanase Innovation AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -22.25%.
As of the last closing price of SEK20.20, shares in Athanase Innovation AB were trading +4.01% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Athanase Innovation AB PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK20.20.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Athanase Innovation AB's management team is headed by:
- Jan Litborn - CHM
- Johan Ericsson - CEO
- Tomas Stahl - DRC
- Christer Wachtmeister - DRC